Literature DB >> 24129430

Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome.

Denise Horn1, Dagmar Wieczorek2, Kay Metcalfe3, Ivo Barić4, Lidija Paležac5, Mario Cuk4, Danijela Petković Ramadža6, Ulrike Krüger1, Stephanie Demuth7, Wolfram Heinritz8, Tobias Linden9, Jens Koenig9, Peter N Robinson1, Peter Krawitz1.   

Abstract

Three different genes of the glycosylphosphatidylinositol anchor synthesis pathway, PIGV, PIGO, and PGAP2, have recently been implicated in hyperphosphatasia-mental retardation syndrome (HPMRS), also known as Mabry syndrome, a rare autosomal recessive form of intellectual disability. The aim of this study was to delineate the PIGV mutation spectrum as well as the associated phenotypic spectrum in a cohort of 16 individuals diagnosed with HPMRS on the basis of intellectual disability and elevated serum alkaline phosphate as minimal diagnostic criteria. All PIGV exons and intronic boundaries were sequenced in 16 individuals. Biallelic PIGV mutations were identified in 8 of 16 unrelated families with HPMRS. The most frequent mutation detected in about 80% of affected families including the cases reported here is the c.1022C>A PIGV mutation, which was found in both the homozygous as well as the heterozygous state. Four further mutations found in this study (c. 176T>G, c.53G>A, c.905T>C, and c.1405C>T) are novel. Our findings in the largest reported cohort to date significantly extend the range of reported manifestations associated with PIGV mutations and demonstrate that the severe end of the clinical spectrum presents as a multiple congenital malformation syndrome with a high frequency of Hirschsprung disease, vesicoureteral, and renal anomalies as well as anorectal malformations. PIGV mutations are the major cause of HPMRS, which displays a broad clinical variability regarding associated malformations and growth patterns. Severe developmental delays, particular facial anomalies, brachytelephalangy, and hyperphosphatasia are consistently found in PIGV-positive individuals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24129430      PMCID: PMC4023216          DOI: 10.1038/ejhg.2013.241

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  7 in total

1.  Phenotypic variability in hyperphosphatasia with seizures and neurologic deficit (Mabry syndrome).

Authors:  Miles D Thompson; Tony Roscioli; Carlo Marcelis; Marjan M Nezarati; Irene Stolte-Dijkstra; Frances J Sharom; Peihua Lu; John A Phillips; Elizabeth Sweeney; Peter N Robinson; Peter Krawitz; Helger G Yntema; Danielle M Andrade; Han G Brunner; David E C Cole
Journal:  Am J Med Genet A       Date:  2012-02-07       Impact factor: 2.802

2.  Hyperphosphatasia-mental retardation syndrome due to PIGV mutations: expanded clinical spectrum.

Authors:  Denise Horn; Peter Krawitz; Anca Mannhardt; Georg Christoph Korenke; Peter Meinecke
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

3.  Developmental abnormalities of glycosylphosphatidylinositol-anchor-deficient embryos revealed by Cre/loxP system.

Authors:  M Nozaki; K Ohishi; N Yamada; T Kinoshita; A Nagy; J Takeda
Journal:  Lab Invest       Date:  1999-03       Impact factor: 5.662

4.  Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation.

Authors:  Peter M Krawitz; Yoshiko Murakami; Jochen Hecht; Ulrike Krüger; Susan E Holder; Geert R Mortier; Barbara Delle Chiaie; Elfride De Baere; Miles D Thompson; Tony Roscioli; Szymon Kielbasa; Taroh Kinoshita; Stefan Mundlos; Peter N Robinson; Denise Horn
Journal:  Am J Hum Genet       Date:  2012-06-07       Impact factor: 11.025

5.  Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome.

Authors:  Peter M Krawitz; Michal R Schweiger; Christian Rödelsperger; Carlo Marcelis; Uwe Kölsch; Christian Meisel; Friederike Stephani; Taroh Kinoshita; Yoshiko Murakami; Sebastian Bauer; Melanie Isau; Axel Fischer; Andreas Dahl; Martin Kerick; Jochen Hecht; Sebastian Köhler; Marten Jäger; Johannes Grünhagen; Birgit Jonske de Condor; Sandra Doelken; Han G Brunner; Peter Meinecke; Eberhard Passarge; Miles D Thompson; David E Cole; Denise Horn; Tony Roscioli; Stefan Mundlos; Peter N Robinson
Journal:  Nat Genet       Date:  2010-08-29       Impact factor: 38.330

6.  Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability.

Authors:  Lars Hansen; Hasan Tawamie; Yoshiko Murakami; Yuan Mang; Shoaib ur Rehman; Rebecca Buchert; Stefanie Schaffer; Safia Muhammad; Mads Bak; Markus M Nöthen; Eric P Bennett; Yusuke Maeda; Michael Aigner; André Reis; Taroh Kinoshita; Niels Tommerup; Shahid Mahmood Baig; Rami Abou Jamra
Journal:  Am J Hum Genet       Date:  2013-04-04       Impact factor: 11.025

7.  PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.

Authors:  Peter M Krawitz; Yoshiko Murakami; Angelika Rieß; Marja Hietala; Ulrike Krüger; Na Zhu; Taroh Kinoshita; Stefan Mundlos; Jochen Hecht; Peter N Robinson; Denise Horn
Journal:  Am J Hum Genet       Date:  2013-04-04       Impact factor: 11.025

  7 in total
  13 in total

1.  pigk Mutation underlies macho behavior and affects Rohon-Beard cell excitability.

Authors:  V Carmean; M A Yonkers; M B Tellez; J R Willer; G B Willer; R G Gregg; R Geisler; S C Neuhauss; A B Ribera
Journal:  J Neurophysiol       Date:  2015-07-01       Impact factor: 2.714

2.  Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia.

Authors:  Periklis Makrythanasis; Mitsuhiro Kato; Maha S Zaki; Hirotomo Saitsu; Kazuyuki Nakamura; Federico A Santoni; Satoko Miyatake; Mitsuko Nakashima; Mahmoud Y Issa; Michel Guipponi; Audrey Letourneau; Clare V Logan; Nicola Roberts; David A Parry; Colin A Johnson; Naomichi Matsumoto; Hanan Hamamy; Eamonn Sheridan; Taroh Kinoshita; Stylianos E Antonarakis; Yoshiko Murakami
Journal:  Am J Hum Genet       Date:  2016-03-17       Impact factor: 11.025

Review 3.  Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling.

Authors:  Taroh Kinoshita; Morihisa Fujita
Journal:  J Lipid Res       Date:  2015-11-12       Impact factor: 5.922

4.  Mutations in PIGY: expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies.

Authors:  Biljana Ilkovski; Alistair T Pagnamenta; Gina L O'Grady; Taroh Kinoshita; Malcolm F Howard; Monkol Lek; Brett Thomas; Anne Turner; John Christodoulou; David Sillence; Samantha J L Knight; Niko Popitsch; David A Keays; Consuelo Anzilotti; Anne Goriely; Leigh B Waddell; Fabienne Brilot; Kathryn N North; Noriyuki Kanzawa; Daniel G Macarthur; Jenny C Taylor; Usha Kini; Yoshiko Murakami; Nigel F Clarke
Journal:  Hum Mol Genet       Date:  2015-08-20       Impact factor: 6.150

5.  Null mutation in PGAP1 impairing Gpi-anchor maturation in patients with intellectual disability and encephalopathy.

Authors:  Yoshiko Murakami; Hasan Tawamie; Yusuke Maeda; Christian Büttner; Rebecca Buchert; Farah Radwan; Stefanie Schaffer; Heinrich Sticht; Michael Aigner; André Reis; Taroh Kinoshita; Rami Abou Jamra
Journal:  PLoS Genet       Date:  2014-05-01       Impact factor: 5.917

6.  Glycosyl phosphatidylinositol anchor biosynthesis is essential for maintaining epithelial integrity during Caenorhabditis elegans embryogenesis.

Authors:  Yemima Budirahardja; Thang Dinh Doan; Ronen Zaidel-Bar
Journal:  PLoS Genet       Date:  2015-03-25       Impact factor: 5.917

7.  Characterization of glycosylphosphatidylinositol biosynthesis defects by clinical features, flow cytometry, and automated image analysis.

Authors:  Alexej Knaus; Jean Tori Pantel; Manuela Pendziwiat; Nurulhuda Hajjir; Max Zhao; Tzung-Chien Hsieh; Max Schubach; Yaron Gurovich; Nicole Fleischer; Marten Jäger; Sebastian Köhler; Hiltrud Muhle; Christian Korff; Rikke S Møller; Allan Bayat; Patrick Calvas; Nicolas Chassaing; Hannah Warren; Steven Skinner; Raymond Louie; Christina Evers; Marc Bohn; Hans-Jürgen Christen; Myrthe van den Born; Ewa Obersztyn; Agnieszka Charzewska; Milda Endziniene; Fanny Kortüm; Natasha Brown; Peter N Robinson; Helenius J Schelhaas; Yvonne Weber; Ingo Helbig; Stefan Mundlos; Denise Horn; Peter M Krawitz
Journal:  Genome Med       Date:  2018-01-09       Impact factor: 11.117

8.  Analysis of exome data for 4293 trios suggests GPI-anchor biogenesis defects are a rare cause of developmental disorders.

Authors:  Alistair T Pagnamenta; Yoshiko Murakami; John M Taylor; Consuelo Anzilotti; Malcolm F Howard; Venessa Miller; Diana S Johnson; Shereen Tadros; Sahar Mansour; I Karen Temple; Rachel Firth; Elisabeth Rosser; Rachel E Harrison; Bronwen Kerr; Niko Popitsch; Taroh Kinoshita; Jenny C Taylor; Usha Kini
Journal:  Eur J Hum Genet       Date:  2017-03-22       Impact factor: 4.246

9.  Hyperphosphatasia with mental retardation syndrome, expanded phenotype of PIGL related disorders.

Authors:  Ruqaiah Altassan; Stephanie Fox; Chantal Poulin; Daniela Buhas
Journal:  Mol Genet Metab Rep       Date:  2018-02-06

10.  Mutations in the PIGW gene associated with hyperphosphatasia and mental retardation syndrome: a case report.

Authors:  Li'na Fu; Yan Liu; Yu Chen; Yi Yuan; Wei Wei
Journal:  BMC Pediatr       Date:  2019-02-27       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.